Violet Zahedi

Violet Zahedi, M.D., serves as the CEO and Co-Founder of Synamics Therapeutics, leading the development of innovative drug discovery methods that integrate evolutionary biology to combat cancer treatment resistance. As a Board Member of the Beacon of Life Foundation, Zahedi contributes to initiatives aimed at transforming cancer into a non-lethal disease through groundbreaking research. With extensive clinical experience gained as a Physician at Region Hovedstaden and a previous role as Medical Advisor at Johnson & Johnson Innovative Medicine, Zahedi possesses a deep understanding of oncology and drug resistance. Additional experience includes significant leadership positions at Novo Nordisk and Rigshospitalet, focusing on clinical trials, patient safety, and hematology research. Zahedi holds a Doctor of Medicine (MD) from Shahid Beheshti University of Medical Sciences and a medical degree equivalency from the University of Copenhagen.